Boston Scientific Stock (BSX) Plunges After Global Cybersecurity Incident
Shares in medical technology group Boston Scientific ($BSX) dipped over 3% in pre-market trading after it revealed it had been hit by a major cyber...
Stryker Corp (SYK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,282,207 | $1,033,370,052 | +111% | 0.46% |
| 2. | Fundsmith LLP Terry Smith | 2,913,833 | $917,391,182 | -5% | 6.72% |
| 3. | Generation Investment Management David Blood And Al Gore | 512,346 | $161,307,015 | 1.57% | |
| 4. | AQR Capital Management Cliff Asness | 476,095 | $149,755,404 | -52% | 0.05% |
| 5. | Point72 Asset Management Steve Cohen | 430,094 | $135,410,795 | +1605% | 0.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $191.94 | 53 | $10,172.82 | 22,070 | 2020-07-31 | Filing | |
| $190.09 | 51 | $9,694.34 | 21,080 | 2020-04-30 | Filing | |
| $216.67 | 45 | $9,750.21 | 20,912 | 2020-01-31 | Filing | |
| $216.77 | 40 | $8,670.78 | 20,867 | 2019-10-31 | Filing | |
| $212.84 | 41 | $8,726.49 | 20,827 | 2019-07-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $328.61 | 441 | $144,914.81 | 6,102 | 2026-08-21 | Filing | |
| $343.47 | 805 | $276,494.96 | 2,251,375 | 2026-08-19 | Filing | |
| $342.80 | 3,852 | $1,320,454.04 | 2,252,180 | 2026-08-19 | Filing | |
| $341.84 | 3,274 | $1,119,180.89 | 2,256,032 | 2026-08-19 | Filing | |
| $340.71 | 16,612 | $5,659,808.07 | 2,259,306 | 2026-08-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 27,414,742 | $8,631,257,137 | 0.13% | |
| 2. | 22,536,843 | $7,095,499,650 | 0.15% | |
| 3. | 17,260,943 | $5,705,087,649 | 0.32% | |
| 4. | 15,532,565 | $4,903,772,337 | 0.15% | |
| 5. | 15,228,545 | $4,794,555,108 | 46.15% |
News See All
Stryker's (SYK) Comeback Quarter Looks Great, But At What Cost?
Stryker (NYSE:SYK) turned in one of its stronger quarters in recent memory on July 30, with sales climbing 9.4% to $6.6 billion and reported EPS jumping 44.1% to $3.30.
Mixed Drivers Fuel Optimism in Stryker Corporation’s (SYK) Performance
Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here.
9 Best Robotics Stocks to Buy as Amazon Deploys 1 Million Robots
The global robotics sector is experiencing an unprecedented boom amid the robust commoditization of hardware and the rapid maturation of physical artificial intelligence and foundation models.
Is Stryker Corporation (SYK) A Good Stock To Buy Now?
Is SYK a good stock to buy? We came across a bullish thesis on Stryker Corporation on MaxDividends’s Substack by Serhio MaxDividends. In this article, we will summarize the bulls’ thesis on SYK.
10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds
On June 9, Reuters reported that Philips' Future Health Index survey concluded that artificial intelligence improved clinical accuracy and increased patient capacity.
10 Set-It-and-Forget-It Stocks to Buy Right Now
A peace pact agreed upon by the United States and Iran on June 18 helped ease concerns about inflation that had been weighing on markets.
10 Best Robotics and Automation Stocks to Invest In
On June 3, CNBC spoke with Softbank CEO Masayoshi Son and Barclays’ Head of Thematic FICC Research Zornitza Todorova.
7 Best Longevity and Anti-Aging Stocks to Buy
The next frontier of human health may not be found in a hospital; it may be unlocked in a laboratory.
16 Stocks on Jim Cramer’s Radar Like Oracle and Goldman Sachs
In this article, we will look at the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been.